Resorbable pouches for implantable medical devices

• US 9,848,955 B2
• Filed: 03/10/2015
• Issued: 12/26/2017
• Est. Priority Date: 11/06/2006
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: TYRX, INC. (Medtronic Plc)
• Inventors: Buevich, Fatima, Moses, Arikha, Do, Frank, McJames, William, Edelman, William, Diamond, Mason
• Primary Examiner(s): OSINSKI, BRADLEY JAMES
• Application Number:
  US14/643,182
• Publication Number:
  US 20150238262A1
• Time in Patent Office: 1,022 Days
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable or resorptive
• CPC Class Codes: A61B 2017/00889 antimicrobial, disinfectant
• CPC Class Codes: A61B 2017/00893 pharmaceutically effective
• CPC Class Codes: A61B 2050/314 Flexible bags or pouches
• CPC Class Codes: A61B 2090/0815 Implantable devices for insertion in between organs or other soft tissues
• CPC Class Codes: A61B 50/30 Containers specially adapted for packaging, protecting, dispensing, collecting or disposing of surgical or diagnostic appliances or instruments for wound clamps A61B17/10; for ligaturing clips A61B17/122; packages or dispensers for surgical gloves or finger-stalls A61B42/40
• CPC Class Codes: A61K 31/195 having an amino group
• CPC Class Codes: A61K 31/445 Non condensed piperidines, e.g. piperocaine
• CPC Class Codes: A61K 31/496 Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• CPC Class Codes: A61L 2300/00 Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
• CPC Class Codes: A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
• CPC Class Codes: A61L 2400/18 Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
• CPC Class Codes: A61L 31/04 Macromolecular materials
• CPC Class Codes: A61L 31/148 Materials at least partially resorbable by the body
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61P 23/00 Anaesthetics
• CPC Class Codes: A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

Biodegradable and resorbable polymer pouches are described for use with cardiac rhythm management devices (CRMs) and other implantable medical devices (IMDs), i.e., a pouch, covering, or other receptacle capable of encasing, surrounding and/or holding the CRM or other IMD for the purpose of securing it in position, inhibiting or reducing bacterial growth, providing pain relief and/or inhibiting scarring or fibrosis on or around the CRM or other IMD. Optionally, the biodegradable and resorbable pouches of the invention include one or more drugs in the polymer matrix to provide prophylactic effects and alleviate side effects or complications associated with the surgery or implantation of the CRM or other IMD.

Claims

1. A kit comprising:

an implantable medical device unit; and

a resorbable pouch comprising a biodegradable and resorbable polymer formed to at least partially enclose or encase said implantable medical device unit and one or more drugs,

wherein said pouch is a thermoformed clamshell type pouch having a first half and a second half connected by a hinge.

2. The kit of claim 1, wherein said medical device unit is a cardiac rhythm management device.

3. The kit of claim 1, wherein said medical device unit is a pacemaker, a defibrillator, a pulse generator, an implantable access system, a drug pump or a neurostimulator.

4. The kit of claim 1, wherein said biodegradable and resorbable polymer is selected from the group consisting of a polylactic acid, polyglycolic acid, poly(L-lactide), poly(D,L-lactide), polyglycolic acid, poly(L-lactide-co-D,L-lactide), poly(L-lactide-co-glycolide), poly(D, L-lactide-co-glycolide), poly(glycolide-co-trimethylene carbonate), poly(D,L-lactide-co-caprolactone), poly(glycolide-co-caprolactone), polyethylene oxide, polyoxaester, polydioxanone, polypropylene fumarate, poly(ethyl glutamate-co-glutamic acid), poly(tert-butyloxy-carbonylmethyl glutamate), polycaprolactone, polycaprolactone co-butylacrylate, polyhydroxybutyrate, poly(phosphazene), poly(phosphate ester), poly(amino acid), polydepsipeptide, maleic anhydride copolymer, polyiminocarbonates, poly[(97.5% dimethyl-trimethylene carbonate)-co-(2.5% trimethylene carbonate)], poly(orthoesters), tyrosine-derived polyarylate, tyrosine-derived polycarbonate, tyrosine-derived polyiminocarbonate, tyrosine-derived polyphosphonate, polyalkylene oxide, hydroxypropylmethylcellulose, polysaccharide, protein, and copolymers, terpolymers and blends of any thereof.

5. The kit of claim 1, wherein said biodegradable and resorbable polymer comprises one or more tyrosine-derived diphenol monomer units.

6. The kit of claim 1, wherein said one or more drugs are selected from the group consisting of antimicrobial agents, anesthetics, analgesics, anti-inflammatory agents, anti-scarring agents, anti-fibrotic agents and leukotriene inhibitors.

7. The kit of claim 1, wherein said one or more drugs is an anesthetic.

8. The kit of claim 1, wherein said one or more drugs is an antimicrobial agent.

9. The kit of claim 8, wherein said antimicrobial agent is selected from the group consisting of rifampin, minocycline, silver/chlorhexidine, vancomycin, a cephalosporin, gentamycin, triclosan and combinations thereof.

10. The kit of claim 8, wherein said antimicrobial agent is two antimicrobial agents, said agents being rifampin and a tetracycline derivative.

11. The kit of claim 1, wherein said pouch is configured to permit ingrowth of tissue into said pouch to resist post implantation migration of said implantable medical device unit.

12. The kit of claim 1, wherein said pouch has a porosity sufficient to electrically ground said implantable medical device unit to tissue surrounding said pouch.

13. The kit of claim 1, wherein said pouch is configured to removably enclose or encase said implantable medical device unit.

14. The kit of claim 1, wherein said implantable medical device unit is movable within said pouch prior to implantation of said pouch and is fixed relative to said pouch following implantation of said pouch.

15. The kit of claim 1, wherein said pouch is woven or knit from resorbable fibers, or made from electrospun resorbable fibers.

16. The kit of claim 1, wherein said biodegradable and resorbable polymer has a molecular weight between about 10,000 and about 20,000 Daltons.

17. The kit of claim 1, wherein said biodegradable and resorbable polymer is a member of the P22-xx family.

18. The kit of claim 1, wherein said biodegradable and resorbable polymer has elastomeric characteristics such that said pouch fits tightly over said implantable medical device unit.

19. A kit comprising:

an implantable medical device unit; and

a resorbable pouch comprising a biodegradable and resorbable polymer formed to at least partially enclose or encase said implantable medical device unit and one or more drugs,

wherein said pouch is a thermoformed clamshell type pouch having a first half and a second half connected by a hinge, and

wherein said biodegradable and resorbable polymer is a member of the P22-xx family having from 5-40% desaminotyrosyl-tyrosine.

20. A kit comprising:

an implantable medical device unit; and

a resorbable pouch comprising a biodegradable and resorbable polymer formed to at least partially enclose or encase said implantable medical device unit and one or more drugs,

wherein said pouch is a thermoformed clamshell type pouch having a first half and a second half connected by a hinge, and

wherein said biodegradable and resorbable polymer is a member of the P22-xx family having from 27.5% desaminotyrosyl-tyrosine.